02.11.2021 SHOP APOTHEKE EUROPE N.V.  NL0012044747

DGAP-News: ​​​​​​​SHOP APOTHEKE EUROPE: PROCESSED THE FIRST E-PRESCRIPTION.


 

DGAP-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): Miscellaneous
​​​​​​​SHOP APOTHEKE EUROPE: PROCESSED THE FIRST E-PRESCRIPTION.

02.11.2021 / 06:45
The issuer is solely responsible for the content of this announcement.


SHOP APOTHEKE EUROPE: PROCESSED THE FIRST E-PRESCRIPTION.


2 November 2021. The first real e-prescriptions have been received and successfully processed by SHOP APOTHEKE EUROPE. This milestone in the company's history was achieved last Thursday October 28 when the first real electronic prescription came in. Since then, further orders have continued to come in, all from the gematik e-Rx pilot in the Berlin-Brandenburg region.

SHOP APOTHEK EUROPE has prepared for the introduction of electronic prescriptions (e-Rx) for more than two years and has been ready since this summer. The processing of the first e-Rx demonstrates that all of SHOP APOTHEKE EUROPE's front- and back-end processes are working smoothly. The gematik e-Rx pilot in Germany started in the Berlin-Brandenburg focus region this July.

After an intense preparation phase, SHOP APOTHEKE EUROPE has now demonstrated that the company is ready to handle electronic prescriptions. "This is a big success for our project team and our company as a whole. We have been working towards this exciting moment for over two years," says CEO Stefan Feltens. "As Germany's leading online pharmacy brand, with our commitment to improving the life of our patients, we are ideally positioned to provide an even better service to our prescription medicine customers."

Following the ongoing pilot phase and a nationwide introduction phase in December, e-prescriptions are expected to become mandatory for all drugs prescribed to people covered by statutory insurance in Germany from 1 January 2022 or later that year. Germany-based patients will then be able to submit their prescriptions directly in the webshop or via the SHOP APOTHEKE app.

SHOP APOTHEKE EUROPE customers will continue to be able to send a paper prescription by regular mail - so patients can choose the method that best fits their needs. However, SHOP APOTHEKE EUROPE expects e-prescriptions to become the standard in Germany after the launch phase: "We expect that our customers will rapidly adopt e-prescriptions and the convenience they offer. Digital services are now part of life for all age groups and we are pleased that we can finally offer our customers this safe and fast way of filling their prescriptions," says Chief Commercial Officer and co-founder Stephan Weber.
 

ABOUT SHOP APOTHEKE EUROPE.
SHOP APOTHEKE EUROPE is one of Europe's leading and fastest-growing online pharmacies, currently operating in Germany, Austria, France, Belgium, Italy, the Netherlands and Switzerland.

Headquartered in the Dutch logistics hub of Sevenum near Venlo with locations in Cologne, Berlin, Munich, Tongeren, Warsaw, Milan, Paris and Eindhoven, SHOP APOTHEKE EUROPE offers its customers a broad range of more than 100,000 original products at attractive prices: OTC, beauty and personal care products as well as prescription drugs, supplemented by high quality natural food and health products, low carb products and sports nutrition. Currently, more than 7 million active customers trust SHOP APOTHEKE EUROPE.

Since safe and reliable pharmaceutical advice are top priorities at SHOP APOTHEKE EUROPE, the e-pharmacy provides comprehensive pharmaceutical consulting services.

In preparation for the introduction of electronic prescriptions in Germany in summer 2021, the company will further improve the customer experience with focus on disease-specific digital medication management services following the acquisition of SMARTPATIENT in January 2021. This is a key part of SHOP APOTHEKE EUROPE's strategy to transform itself from a pure online retailer into a truly customer-centric e-pharmacy platform.

SHOP APOTHEKE EUROPE N.V. has been listed on the regulated market of the Frankfurt Stock Exchange (Prime Standard) since 2016 and is part of the SDAX stock index.
 

PRESS CONTACTS.

Trade and popular media:
Sven Schirmer
Tel: +49 221 99 53 44 31
Email: [email protected]

Financial media:
Bettina Fries
Tel: +49 211 75 80 779
Email: [email protected]

Investor relations:
Carmen Herkenrath
Tel.: +31 77 850 6109
Email: [email protected]

Thomas Schnorrenberg
Mobile: +49 151 465 31317
Email: [email protected]



02.11.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: SHOP APOTHEKE EUROPE N.V.
Dirk Hartogweg 14
5928 LV Venlo
Netherlands
Phone: 0800 - 200 800 300
Fax: 0800 - 90 70 90 20
E-mail: [email protected]
Internet: www.shop-apotheke-europe.com
ISIN: NL0012044747, DE000A19Y072
WKN: A2AR94, A19Y07
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1245248

 
End of News DGAP News Service

1245248  02.11.2021 

fncls.ssp?fn=show_t_gif&application_id=1245248&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2016 2017 2018 2019 2020 2021 2022e
Umsatzerlöse1 177,39 283,99 539,71 701,01 968,06 1.060,32 1.270,00
EBITDA1,2 -8,84 -12,14 -15,56 -18,58 15,20 -38,73 -25,00
EBITDA-Marge3 -4,98 -4,27 -2,88 -2,65 1,57 -3,65 -1,97
EBIT1,4 -11,64 -19,20 -28,73 -33,45 -0,87 -65,70 -52,00
EBIT-Marge5 -6,56 -6,76 -5,32 -4,77 -0,09 -6,20 -4,09
Jahresüberschuss1 -18,45 -21,36 -33,61 -36,27 -16,77 -74,19 -57,00
Netto-Marge6 -10,40 -7,52 -6,23 -5,17 -1,73 -7,00 -4,49
Cashflow1,7 -17,21 -23,24 -23,54 -30,37 17,80 11,64 19,00
Ergebnis je Aktie8 -2,03 -2,25 -2,79 -2,78 -1,17 -4,15 -3,00
Dividende8 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2021 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: Mazars

INVESTOR-INFORMATIONEN
©boersengefluester.de
Shop Apotheke Europe
WKN Kurs in € Einschätzung Börsenwert in Mio. €
A2AR94 88,000 Halten 1.601,54
KGV 2023e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
110,00 0,00 0,00 -43,56
KBV KCV KUV EV/EBITDA
3,86 137,65 1,51 -34,53
Dividende '20 in € Dividende '21e in € Div.-Rendite '21e
in %
Hauptversammlung
0,00 0,00 0,00 14.04.2022
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
05.05.2022 03.08.2022 31.10.2022 02.03.2022
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
2,70% -19,00% -22,26% -47,12%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu SHOP APOTHEKE EUROPE N.V.  ISIN: NL0012044747 können Sie bei DGAP abrufen


E-Commerce , A2AR94 , SAE , XETR:SAE